Cart
sales@molnova.com
Xemilofiban
CAS No. 149820-74-6
Xemilofiban( —— )
Catalog No. M34736 CAS No. 149820-74-6
Xemilofiban (SC 54684A) interrupts platelet aggregation, promotes thrombosis, and is used in the study of unstable angina.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 509 | In Stock |
|
| 5MG | 770 | In Stock |
|
| 10MG | 1036 | In Stock |
|
| 25MG | 1520 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXemilofiban
-
NoteResearch use only, not for human use.
-
Brief DescriptionXemilofiban (SC 54684A) interrupts platelet aggregation, promotes thrombosis, and is used in the study of unstable angina.
-
DescriptionXemilofiban (SC 54684A) interrupts platelet aggregation, promotes thrombosis, and is used in the study of unstable angina.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number149820-74-6
-
Formula Weight358.39
-
Molecular FormulaC18H22N4O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](NC(CCC(NC1=CC=C(C(=N)N)C=C1)=O)=O)(CC(OCC)=O)C#C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CAY10781
CAY10781 is an inhibitor of the protein-protein interaction between neuropilin-1 (NRP-1) and VEGF-A.1It inhibits the interaction by 43% when used at a concentration of 12.5 μM. CAY10781 also inhibits VEGF-A-induced phosphorylation of VEGFR2 in catecholamine A-differentiated (CAD) cells when used at the same concentration.
-
Di-O-methylbergenin
Di-O-methylbergenin is a natural product for research related to life sciences.
-
Ac2-26 TFA
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
